keyword
https://read.qxmd.com/read/38700147/a-case-of-pitt-hopkins-syndrome-psychopharmacological-approach-for-anxiety-insomnia-and-agitation
#1
JOURNAL ARTICLE
Cemre Istanbullu, Binay Kayan Ocakoglu, Gul Karacetin
Pitt-Hopkins syndrome (PTHS) is a rare genetic disorder resulting from TCF4 gene mutations which is characterized by dysmorphic facial features, psychomotor delay, intellectual disability, breathing anomalies, and seizures. Psychiatric conditions are occasionally seen. We present the case report of a seven-year-old PTHS patient with anxiety, insomnia, and agitation. We discuss the psychopharmacological intervention options for this patient. The present case study reports on a 7-year-old female with PTHS, autism spectrum disorder (ASD), and intellectual disability...
May 3, 2024: Neurocase
https://read.qxmd.com/read/38669366/cerebrotendinous-xanthomatosis-with-tremor-as-the-main-manifestation-a-case-report
#2
JOURNAL ARTICLE
Wei Zhao, Jie Han, Dingbo Tao, Hongliang Zheng
INTRODUCTION: Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive lipid metabolism disorder. It is caused by a defect in the sterol-27-hydroxylase gene, leading to the deposition of cholesteryl and bile alcohol in large amounts, causing a variety of clinical manifestations; however, tremor as the main manifestation of CTX has not been reported. PATIENTS CONCERNS AND CLINICAL FINDINGS: Herein, we report a 27-year-old woman, who developed head and body tremors at the age of 12 years...
April 26, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38566853/hemimasticatory-spasm-a-series-of-17-cases-and-a-comprehensive-review-of-the-literature
#3
JOURNAL ARTICLE
Kazuya Yoshida
Hemimasticatory spasm (HMS) is a rare movement disorder characterized by paroxysmal spasms or twitches of the unilateral jaw-closing muscles. This study aimed to comprehensively evaluate the clinical features of patients with HMS. Data from 17 patients newly diagnosed with HMS (12 females and 5 males; mean age at onset: 46.7 years) who visited our department were retrospectively analyzed, and a literature search based on electronic medical databases from their inception until November 30, 2023, was conducted...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38531021/neurodevelopmental-and-functional-outcomes-following-in-utero-exposure-to-antiseizure-medication-a-systematic-review
#4
JOURNAL ARTICLE
Eliza Honybun, Emily Cockle, Charles B Malpas, Terence J O'Brien, Frank J Vajda, Piero Perucca, Genevieve Rayner
BACKGROUND AND OBJECTIVES: To undertake a systematic review of the available literature to examine the relationship between prenatal antiseizure medication (ASM) exposure and adverse postnatal neurodevelopmental outcomes, focusing on social, emotional, behavioral, and adaptive domains of human function, and the frequency of neurodevelopmental and psychiatric disorders in ASM-exposed offspring. METHODS: Electronic searches of MEDLINE, PsychINFO, and EMBASE were conducted and limited to studies published between 1990 and 2023 in English...
April 23, 2024: Neurology
https://read.qxmd.com/read/38500267/the-effective-perospirone-augmentation-with-clonazepam-for-treatment-resistant-burning-mouth-syndrome-a-case-report
#5
Motoko Watanabe, Chihiro Takao, Chizuko Maeda, Gayatri Nayanar, Risa Tominaga, Yasuyuki Kimura, Trang Thi Huyen Tu, Takahiko Nagamine, Akira Toyofuku
Burning mouth syndrome (BMS) is characterized by burning sensations in the oral region without corresponding abnormalities and is often accompanied by uncomfortable sensations. Herein, we present cases of BMS in which the remaining uncomfortable sensations improved with perospirone augmentation with clonazepam. Case 1: A 61-year-old man complained of a burning pain in his tongue, a sensation of dryness and discomfort as if his tongue was sticking to a palatal plate. With the diagnosis of BMS, psychopharmacotherapy was initiated with amitriptyline...
March 18, 2024: Neuropsychopharmacology Reports
https://read.qxmd.com/read/38494993/minimal-effect-of-long-term-clonazepam-on-cognitive-function-in-patients-with-isolated-rbd
#6
JOURNAL ARTICLE
Minji Lee, Tong Keon Kim, Jung Kyung Hong, In-Young Yoon
STUDY OBJECTIVES: Despite its widespread use in patients with isolated rapid eye movement sleep behavior disorder (iRBD), the cognitive effect of clonazepam is uncertain. This study aimed to investigate effect of cumulative clonazepam on cognitive function in patients with iRBD. METHODS: Demographic characteristics, baseline cognitive test, and most recent cognitive test information were collected retrospectively. Based on cumulative clonazepam doses, patients were classified into four subgroups: group 1 < 365 mg (1 mg * 1 year); 365 mg ≤ group 2 < 1,095 mg (1 mg * 3 years); 1,095 mg ≤ group 3 < 2,190 mg (1 mg * 6 years); and group 4 ≥ 2,190 mg...
March 18, 2024: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://read.qxmd.com/read/38484346/a-rare-clinical-presentation-of-covid-19-opsoclonus-myoclonus-ataxia-syndrome
#7
JOURNAL ARTICLE
Adalet Altunsoy, Nizamettin Kemirtlek, Halime Araz, Ebru Bilge Dirik, Esragül Akıncı
INTRODUCTION: Coronavirus disease 2019 (COVID-19) can have symptoms like many neurological diseases, and one of the rare forms of these presentations is opsoclonus-myoclonus ataxia syndrome (OMAS). The pathogenesis of OMAS in adults has not been clearly elucidated and OMAS can be fatal. CASE PRESENTATION: We present a 71-year-old male patient who was admitted to the emergency department with complaints of involuntary tremor-like movements in his hands, feet and mouth, and speech impediment for three days, and was followed up with COVID-19...
February 29, 2024: Journal of Infection in Developing Countries
https://read.qxmd.com/read/38477725/psychoactive-substance-consumption-after-the-fund%C3%A3-o-dam-mine-tailing-disaster-in-minas-gerais-state-brazil
#8
JOURNAL ARTICLE
Elaine Silva Miranda, Marcelo Dell'Aringa, Everaldo Alves da Costa, Thais Piazza, Francesco Della Corte, Luca Ragazzoni, Francesco Barone-Adesi, Carla Lourenço Tavares de Andrade, Claudia Garcia Serpa Osorio-de-Castro
Disasters cause changes in morbidity, mortality, and medicine use. Brazil is one of the main producers of mineral ores at great environmental cost. Mine tailings are stored in dams and ruptures have led to major disasters. We investigated the consumption of psychoactive medicines in the municipalities affected by the Fundão dam disaster in Minas Gerais State. An ecological study was carried out on drug consumption, estimated using public purchases in Minas Gerais and dispensing data from private retail pharmacies...
2024: Cadernos de Saúde Pública
https://read.qxmd.com/read/38476755/prenatal-exposure-to-antiseizure-medications-and-fetal-growth-a-population-based-cohort-study-from-the-nordic-countries
#9
JOURNAL ARTICLE
Jakob Christensen, Helga Zoega, Maarit K Leinonen, Nils Erik Gilhus, Mika Gissler, Jannicke Igland, Yuelian Sun, Torbjörn Tomson, Silje Alvestad, Marte-Helene Bjørk, Julie Werenberg Dreier
BACKGROUND: The short- and long-term consequences of restricted fetal growth cause considerable concern, and how prenatal exposure to different antiseizure medications (ASMs) affects fetal growth remains uncertain. METHODS: This was a population-based cohort study of liveborn singleton children born in Denmark, Finland, Iceland, Norway, and Sweden from 1996 to 2017. Prenatal exposure was defined as maternal filling of prescriptions for ASM during pregnancy registered in national prescription registries and primary outcomes were adjusted odds ratios (aORs) of microcephaly or being born small for gestational age...
March 2024: The Lancet regional health. Europe
https://read.qxmd.com/read/38471116/designing-molecularly-imprinted-polymer-modified-boron-doped-diamond-electrodes-for-highly-selective-electrochemical-drug-sensors
#10
JOURNAL ARTICLE
Kanako Ishii, Genki Ogata, Takashi Yamamoto, Shuyi Sun, Hiroshi Shiigi, Yasuaki Einaga
Drug detection in biological solutions is essential in studying the pharmacokinetics of the body. Electrochemical detection is an accurate and rapid method, but measuring multiple drugs that react at similar potentials is challenging. Herein, we developed an electrochemical sensor using a boron-doped diamond (BDD) electrode modified with a molecularly imprinted polymer (MIP) to provide specificity in drug sensing. The MIP is a polymer material designed to recognize and capture template molecules, enabling the selective detection of target molecules...
March 12, 2024: ACS Sensors
https://read.qxmd.com/read/38456812/sleep-related-painful-erections-treated-with-sodium-oxybate
#11
Hira S Chaudhary, Eric Zeidman, Nahid Punjani, Yasemin Tashman
A 39-year-old male with a medical history significant for migraine, psoriatic arthritis, postural orthostatic tachycardia syndrome (POTS), vitamin D deficiency and hypoglycemia presented with a two-year history of sleep-related painful erections (SRPE). Since the reported prevalence is low, there is limited understanding of the possible etiologies of the disorder and little published clinical data on treatment algorithms. Thus, he had tried multiple therapies. Baclofen was effective but not tolerated. Pelvic physiotherapy and tadalafil were ineffective...
March 8, 2024: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://read.qxmd.com/read/38451521/drug-efficacy-in-the-treatment-of-antipsychotic-induced-akathisia-a-systematic-review-and-network-meta-analysis
#12
JOURNAL ARTICLE
Cyril Gerolymos, Romain Barazer, Dong Keon Yon, Anderson Loundou, Laurent Boyer, Guillaume Fond
IMPORTANCE: Antipsychotic-induced akathisia (AIA) occurs in 14% to 35% of patients treated with antipsychotics and is associated with increased suicide and decreased adherence in patients with schizophrenia. However, no comprehensive review and network meta-analysis has been conducted to compare the efficacy of treatments for AIA. OBJECTIVE: To compare the efficacy associated with AIA treatments. DATA SOURCES: Three databases (MEDLINE, Web of Science, and Google Scholar) were systematically searched by multiple researchers for double-blind randomized clinical trials (RCTs) comparing active drugs for the treatment of AIA with placebo or another treatment between May 30 and June 18, 2023...
March 4, 2024: JAMA Network Open
https://read.qxmd.com/read/38445139/a-naturalistic-non-interventional-investigation-of-the-clinical-and-sociodemographic-characteristics-and-prescription-patterns-in-patients-with-psychotic-disorders-at-a-tertiary-care-facility-in-south-asia
#13
JOURNAL ARTICLE
Zarrin Ansari, Abhilasha Rashmi, Sudhir Pawar
OBJECTIVES:  This study aimed to evaluate the trends in the sociodemographic, clinical, and prescription characteristics of patients with psychotic illnesses seen in the outpatient psychiatry department of a tertiary care facility. METHODS:  Between March 2021 and April 2022, a cross-sectional, prospective, observational, naturalistic, non-interventional study was conducted. A total of two hundred prescriptions were analyzed. To assess the rationality of prescriptions, World Health Organization (WHO) indicators were also computed...
February 2024: Curēus
https://read.qxmd.com/read/38421131/polysomnographic-features-associated-with-clonazepam-and-melatonin-treatment-in-isolated-rem-sleep-behavior-disorder-time-for-new-therapeutic-approaches
#14
JOURNAL ARTICLE
Maria P Mogavero, Raffaele Ferri, Sara Marelli, Giuseppe Lanza, Michele Terzaghi, Alessandra Castelnuovo, Lourdes M DelRosso, Carlos H Schenck, Luigi Ferini-Strambi
AIMS: Although clonazepam (CLO) and melatonin (MLT) are the most frequently used treatments for REM sleep behavior disorder, the polysomnographic features associated with their use are little known. The aim of this study was to evaluate polysomnographic and clinical parameters of patients with idiopathic/isolated REM sleep behavior disorder (iRBD) treated chronically with CLO, sustained-release MLT, alone or in combination, and in a group of drug-free iRBD patients. METHODS: A total of 96 patients were enrolled: 43 drug-free, 21 with CLO (0...
February 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38415847/managing-paediatric-convulsive-status-epilepticus-how-useful-is-intravenous-clonazepam
#15
JOURNAL ARTICLE
Janet Mifsud
No abstract text is available yet for this article.
February 28, 2024: Developmental Medicine and Child Neurology
https://read.qxmd.com/read/38410526/tongue-biting-event-in-patients-with-sleep-related-facial-mandibular-myoclonus-a-case-series-study
#16
JOURNAL ARTICLE
Gengyao Hu, Yuanhang Pan, Na Yuan, Zhixian Yang, Xiuyu Shi, Sha Ma, Shan Li, Xiaohua Hou, Fei Liu, Dongmei Li, Junxiang Bao, Yonghong Liu
BACKGROUND: Sleep-related facial mandibular myoclonus (SRFMM) remains rare in clinical practice. The aim of this study was to provide a comprehensive understanding of the electroclinical manner, therapeutic regimen, and prognosis of SRFMM. METHODS: Twenty-three patients who were diagnosed with SRFMM by clinical manifestation, video-electroencephalography (EEG) and electromyography over bilateral masseter and temporalis muscles were enrolled. Clinical and electrophysiological evaluation as well as follow-up information were recorded and analyzed...
2024: Nature and Science of Sleep
https://read.qxmd.com/read/38407908/prenatal-exposure-to-antiseizure-medications-and-risk-of-epilepsy-in-children-of-mothers-with-epilepsy
#17
JOURNAL ARTICLE
Julie Werenberg Dreier, Jakob Christensen, Jannicke Igland, Mika Gissler, Maarit K Leinonen, Håkon Magne Vegrim, Yuelian Sun, Torbjörn Tomson, Helga Zoega, Marte-Helene Bjørk, Rebecca L Bromley
IMPORTANCE: Use of valproate and certain other antiseizure medications (ASMs) in pregnancy is associated with abnormal fetal brain development with potential long-term implications for the child. OBJECTIVE: To examine whether use of valproate and other ASMs in pregnancy among mothers with epilepsy is associated with epilepsy risk in their children. DESIGN, SETTING, AND PARTICIPANTS: This prospective, population-based register cohort study included singletons born to mothers with epilepsy in Denmark, Finland, Iceland, Norway, and Sweden from January 1, 1996, to December 31, 2017...
February 5, 2024: JAMA Network Open
https://read.qxmd.com/read/38382407/seizure-control-and-complications-in-patients-switching-from-clobazam-to-clonazepam-due-to-drug-shortage
#18
JOURNAL ARTICLE
Oğuzhan Fırat, Melike Çakan, Kutay Demirkan, Neşe Dericioğlu
BACKGROUND: Antiseizure medication (ASM) shortages are a global problem that have a negative impact on outcomes such as seizure control in patients with epilepsy (PWE). In the case of clobazam (CLB) shortage, there is no study regarding the management strategy. This study aims to investigate the alteration in seizure frequency and the occurrence of side effects in PWE undergoing an abrupt switch from clobazam (CLB) to clonazepam (CLZ), during CLB shortage. MATERIAL AND METHODS: A retrospective study was conducted from electronic health records at our neurology outpatient clinic from January to July 2022...
February 20, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38369327/-a-case-of-stiff-person-syndrome-with-muscle-tonicity-of-the-extremities-and-neck-after-use-of-dulvalumab-for-lung-adenocarcinoma
#19
JOURNAL ARTICLE
Takashi Inoue, Kei Oiwa, Kazuhiro Horiuchi
A 74-year-old woman taking dulvalumab for lung adenocarcinoma developed muscle tonicity in the extremities and trunk. Painful paroxysmal muscle spasms with profuse sweating were frequently observed, and surface electromyography showed simultaneous contraction of the active and antagonist muscles. Blood tests were strongly positive for anti-amphiphysin antibodies, and stiff-person syndrome (SPS) was diagnosed. Intravenous immunoglobulin therapy and clonazepam were initiated, and the paroxysmal painful muscle spasms disappeared...
February 17, 2024: Rinshō Shinkeigaku, Clinical Neurology
https://read.qxmd.com/read/38368072/rapid-eye-movement-sleep-behavior-disorder-management-and-prognostic-counseling
#20
REVIEW
Roneil Malkani
Management of rapid eye movement sleep behavior disorder (RBD) includes reducing injurious dream-enactment behaviors, risk of injury to self and bedpartner, and vivid or disruptive dreams and improving sleep quality and bedpartner sleep disruption. Safety precautions should be reviewed at each visit. Medications to reduce RBD symptoms such as melatonin, clonazepam, pramipexole, and rivastigmine should be considered for most patients. Isolated RBD confers a high lifetime risk of neurodegenerative diseases with a latency often spanning many years...
March 2024: Sleep Medicine Clinics
keyword
keyword
14482
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.